Showing 321 - 340 results of 117,004 for search '(( 5 ((((a decrease) OR (we decrease))) OR (mean decrease)) ) OR ( a non decrease ))', query time: 1.93s Refine Results
  1. 321

    Decreased Memory B Cells and Increased CD8 Memory T Cells in Blood of Breastfed Children: The Generation R Study by Michelle A. E. Jansen (740955)

    Published 2015
    “…</p><p>Results</p><p>Per month continuation of breastfeeding, a 3% (95% CI -6, -1) decrease in CD27+IgM+, a 2% (95 CI % -5, -1) decrease in CD27+IgA+ and a 2% (95% CI -4, -1) decrease in CD27-IgG+ memory B cell numbers were observed at 6 months of age. …”
  2. 322
  3. 323
  4. 324
  5. 325
  6. 326
  7. 327

    Resveratrol decreased intracellular levels of R5P. by Mohd Askandar Iqbal (324124)

    Published 2013
    “…<p>R5P is a pentose phosphate pathway intermediate, an important marker for anabolism (nucleotide biosynthesis). …”
  8. 328

    Decreased Tks5 expression results in neural crest-derived defects. by Danielle A. Murphy (212554)

    Published 2011
    “…<p>(A–B) Melanophores within the trunk region above the yolk sac extension in control MO-injected and Tks5 MO-injected embryos were qualitatively (A) and quantitatively (B) analyzed. n = 15 embryos and SEM is shown by bar. p values obtained from Student's t-test. ** denotes p<0.01. …”
  9. 329
  10. 330
  11. 331

    (a) Dependence of δ on η with κ = 2.0 by Shu-Wei Song (557396)

    Published 2013
    “…As the spin–orbit coupling strength gets larger and larger, the spatial displacement decreases at a rate inversely proportional to the spin–orbit coupling strength. …”
  12. 332

    Ether induces proteotoxic stress, leading to a decrease in Trx protein and an increase in Hsp90 clients that are joint targets of Trx and Ubx. by Orli Snir (18625811)

    Published 2024
    “…<b>(F)</b> Representative images of Acridine Orange-stained <i>yw</i> embryos for the following cases: no treatment (up left), 5-min immersion in Citrasolv solution [<a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3002629#pbio.3002629.ref046" target="_blank">46</a>] (up right), 5-min immersion in ether liquid (bottom right), and 1.5-h exposure to ether vapor (bottom left). …”
  13. 333
  14. 334

    Heterologous Immunity Triggered by a Single, Latent Virus in <i>Mus musculus</i>: Combined Costimulation- and Adhesion- Blockade Decrease Rejection by Jonathan M. Beus (441623)

    Published 2013
    “…<div><p>The mechanisms underlying latent-virus-mediated heterologous immunity, and subsequent transplant rejection, especially in the setting of T cell costimulation blockade, remain undetermined. To address this, we have utilized MHV68 to develop a rodent model of latent virus-induced heterologous alloimmunity. …”
  15. 335

    MAP-2 decrease follows the early PSA-NCAM reduction induced by glutamate exposure. by María Fernanda Podestá (639243)

    Published 2014
    “…MAP-2 and PSA-NCAM immunoreactive areas are expressed as mean values (±SEM) of 20–30 neurons per experimental condition. ns, non-significant; *** P<0.001 between bars, non-parametric Mann-Whitney test. …”
  16. 336
  17. 337

    Influence of the Lactotripeptides Isoleucine–Proline–Proline and Valine–Proline–Proline on Systolic Blood Pressure in Japanese Subjects: A Systematic Review and Meta-Analysis of Ra... by Aurelie Chanson-Rolle (758940)

    Published 2015
    “…We performed a meta-analysis including all published studies to evaluate the SBP-lowering effect of IPP/VPP in Japanese subjects more comprehensively.…”
  18. 338

    Pharmacological Mechanism of the Non-hallucinogenic 5‑HT<sub>2A</sub> Agonist Ariadne and Analogs by Michael J. Cunningham (14267038)

    Published 2022
    “…Compared to DOM, Ariadne shows lower signaling potency and efficacy in multiple signaling pathways examined (G<sub>q</sub>, G<sub>11</sub>, and β-arrestin2) coupled to 5-HT<sub>2A</sub> receptors. We confirmed the shift in signaling for an α-propyl analog and provide a molecular docking rationale for the progressive decrease in signaling potency with the growing length of the α-substituent. …”
  19. 339

    Pharmacological Mechanism of the Non-hallucinogenic 5‑HT<sub>2A</sub> Agonist Ariadne and Analogs by Michael J. Cunningham (14267038)

    Published 2022
    “…Compared to DOM, Ariadne shows lower signaling potency and efficacy in multiple signaling pathways examined (G<sub>q</sub>, G<sub>11</sub>, and β-arrestin2) coupled to 5-HT<sub>2A</sub> receptors. We confirmed the shift in signaling for an α-propyl analog and provide a molecular docking rationale for the progressive decrease in signaling potency with the growing length of the α-substituent. …”
  20. 340